Company profile
ClostraBio company profile
ClostraBio develops drugs that can prevent allergic reactions to food. It is dedicated to understanding and treating food allergies and other diseases of the immune system. The company is discovering and developing new therapeutics that modulate the protective ability of the microbe. ClostraBio’s scientific team has made key discoveries that highlight the importance of the intestinal microbiota in regulating allergic sensitization to food. The company is committed to a deeper understanding of the role of intestinal microbes in gut barrier function and determining the mechanisms of barrier protection.
Business identity
- Website
- http://www.clostrabio.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Victoria, Virginia, United States
- Country code
- US
- Continent
- North America